Search research articles
Contact Us
Filters
Showing results (31-40 of 468) with videos related to
Page
of 47
Sort By:
Nature Reviews. Drug Discovery
|
February 25, 2017
Regulatory watch: From big data to smart data: FDA's INFORMED initiative
Sean Khozin, Geoffrey Kim, Richard Pazdur
Nature Reviews. Clinical Oncology
|
February 24, 2023
Approvals in 2022: overall survival, dose optimization, new approvals and beyond
Deepti Telaraja, Nicole Gormley, Richard Pazdur
Journal of Biopharmaceutical Statistics
|
March 19, 2004
Assessing tumor-related signs and symptoms to support cancer drug approval
Grant Williams, Richard Pazdur, Robert Temple
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration
Lilia Talarico, Gang Chen, Richard Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access Programs
Tamy Kim, Peter Lurie, Richard Pazdur
Nature Reviews. Drug Discovery
|
April 7, 2018
INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology
Sean Khozin, Richard Pazdur, Anand Shah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015
Susan Jin, Richard Pazdur, Rajeshwari Sridhara
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 2, 2018
Leveraging the Success of HIV Drug Development Paradigms for Cancer
Gideon M Blumenthal, Debra Birnkrant, Richard Pazdur
JAMA Oncology
|
October 28, 2021
Immunotherapy for Patients With Small-Cell Lung Cancer-2 Gains, 2 Losses
Harpreet Singh, Julia A Beaver, Richard Pazdur
JAMA Oncology
|
April 15, 2021
Evaluating Cancer Drugs in Patients With Central Nervous System Metastases
Shanthi Marur, Julia A Beaver, Richard Pazdur
Page
of 47
Search research articles
Search
Showing results (31-40 of 468) with videos related to
Sort By:
Page
of 47
Nature Reviews. Drug Discovery
|
February 25, 2017
Regulatory watch: From big data to smart data: FDA's INFORMED initiative
Sean Khozin, Geoffrey Kim, Richard Pazdur
Nature Reviews. Clinical Oncology
|
February 24, 2023
Approvals in 2022: overall survival, dose optimization, new approvals and beyond
Deepti Telaraja, Nicole Gormley, Richard Pazdur
Journal of Biopharmaceutical Statistics
|
March 19, 2004
Assessing tumor-related signs and symptoms to support cancer drug approval
Grant Williams, Richard Pazdur, Robert Temple
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 16, 2004
Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration
Lilia Talarico, Gang Chen, Richard Pazdur
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
US Food and Drug Administration Efforts to Facilitate the Use of Expanded Access Programs
Tamy Kim, Peter Lurie, Richard Pazdur
Nature Reviews. Drug Discovery
|
April 7, 2018
INFORMED: an incubator at the US FDA for driving innovations in data science and agile technology
Sean Khozin, Richard Pazdur, Anand Shah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 3, 2017
Re-Evaluating Eligibility Criteria for Oncology Clinical Trials: Analysis of Investigational New Drug Applications in 2015
Susan Jin, Richard Pazdur, Rajeshwari Sridhara
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 2, 2018
Leveraging the Success of HIV Drug Development Paradigms for Cancer
Gideon M Blumenthal, Debra Birnkrant, Richard Pazdur
JAMA Oncology
|
October 28, 2021
Immunotherapy for Patients With Small-Cell Lung Cancer-2 Gains, 2 Losses
Harpreet Singh, Julia A Beaver, Richard Pazdur
JAMA Oncology
|
April 15, 2021
Evaluating Cancer Drugs in Patients With Central Nervous System Metastases
Shanthi Marur, Julia A Beaver, Richard Pazdur
Page
of 47